Breast cancer surgery aims to eliminate malignant tissue while preserving healthy anatomical structures and cosmetic integrity whenever clinically appropriate. Conducted within the specialty of surgical oncology, the intervention spans breast-conserving procedures, complete tissue resection, and regional axillary staging. Surgical planning integrates tumor biology, clinical stage, genomic profiling, and individual patient values.

Breast cancer surgery begins with patient positioning under general anesthesia. For non-palpable lesions, preoperative wire or magnetic seed localization guides the initial skin incision. The surgeon makes an incision planned for optimal oncologic access and cosmetic outcome. Malignant tissue is removed with a surrounding rim of normal tissue to achieve clear negative margins. Axillary assessment is performed concurrently via sentinel lymph node biopsy using radioisotope or fluorescent dye tracking. Specimens are marked for orientation and transferred to pathology. Hemostasis is achieved, surgical drains are placed if required, and deep tissue layers and skin are closed using absorbable sutures.

Surgical intervention provides definitive local disease control, clear pathological identification of tumor margins, accurate staging of regional lymph nodes, and tissue for biomarker refinement. Clinical registry data consistently show that achieving clear surgical margins significantly reduces local recurrence risk and provides essential prognostic parameters that dictate personalized systemic treatment regimens.

Recovery timelines vary according to surgical extent. Patients undergoing breast-conserving surgery typically resume light routine activities within 1 to 2 weeks. Patients undergoing total mastectomy or immediate breast reconstruction require 4 to 6 weeks for physical restoration. Shoulder mobility exercises, wound monitoring, and drain management form essential components of early post-operative rehabilitation.

Breast cancer surgery treats early-stage and locally advanced malignant conditions. Key indications include ductal carcinoma in situ (DCIS), invasive ductal carcinoma, invasive lobular carcinoma, inflammatory breast cancer, phyllodes tumors, and local recurrences of primary breast malignancies.

Preoperative preparation includes a full diagnostic workup consisting of mammography, ultrasound, or magnetic resonance imaging (MRI), and core needle biopsy. Comprehensive medical evaluation includes routine blood work, baseline electrocardiogram (ECG), and medication review. Patients must stop blood-thinning medications under specialist guidance prior to surgery. Fasting protocols usually dictate no solid food for eight hours before anesthesia. Preoperative marking or radiological localization procedures occur either the morning of or the day before surgery.

Complications associated with breast cancer surgery include wound infection, hematoma formation, seroma accumulation requiring aspiration, persistent post-mastectomy pain syndrome, and impaired arm or shoulder mobility. Axillary lymph node dissection carries a distinct risk of secondary lymphedema, a chronic swelling of the upper extremity. Rare surgical risks include skin flap necrosis, wound dehiscence, deep vein thrombosis, and risks inherent to general anesthesia.

The surgical journey begins with a clinical evaluation, diagnostic imaging, and tissue biopsy to establish pathological diagnosis. Pre-operative preparation includes tumor localization and multidisciplinary discussion. Surgical intervention involves breast tissue resection paired with sentinel lymph node biopsy or axillary dissection. Post-operative care focuses on wound healing, functional recovery, pathological review, and seamless transition to recommended systemic or radiation treatments.